Globoid Leukodystrophy: Clinical Trials

2 trials for Globoid Leukodystrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. .

Follow Globoid Leukodystrophy: new trials by email Literature Review of Globoid Leukodystrophy trials Research Report on Globoid Leukodystrophy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Leukodystrophy, White Matter Disease
CompletedChildren's Hospital of Philadelphia2362017-01-062025-11-10
The Myelin Disorders Biorepository Project
Leukodystrophy, White Matter Disease
RecruitingChildren's Hospital of Philadelphia120002016-12-082025-10-23

Narrower conditions

Adrenoleukodystrophy (2)  ·  Aicardi-Goutieres syndrome (2)  ·  Alexander Disease (2)  ·  Alexanders leukodystrophy (2)  ·  Allan-Herndon-Dudley syndrome (2)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  CADASIL (2)  ·  Canavan Disease (2)  ·  Charcot-Marie-Tooth Disease (2)  ·  Cockayne Syndrome (2)  ·  Gangliosidoses (2)  ·  Gangliosidoses, GM2 (2)  ·  Leukodystrophy, Globoid Cell (2)  ·  Leukodystrophy, Hypomyelinating, 5 (2)  ·  Leukodystrophy, Hypomyelinating, 6 (2)

Broader conditions

Abnormalities, Multiple (2)  ·  Adrenal Gland Diseases (2)  ·  Adrenal Insufficiency (2)  ·  Arthritis (2)  ·  Arthritis, Rheumatoid (2)  ·  Attention Deficit and Disruptive Behavior Disorders (2)  ·  Autoimmune Diseases (2)  ·  Bone Diseases (2)  ·  Bone Diseases, Developmental (2)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Brain Infarction (2)  ·  Brain Ischemia (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)

Sponsors

Children's Hospital of Philadelphia (2)

Countries

United States (2)

Top investigators

Adeline Vanderver, MD (2)

Results publications

PMID 32342562, PMID 32749716

NIH funding

U01NS106845 (1), U54NS115052 (1)